San Juan Capistrano, Calif.--Two devices for creating minimally invasive dialysis access--the Ellipsys® Vascular Access System and the WavelinQ™ 4F System--demonstrated high rates of technical success ...

SAN JUAN CAPISTRANO, Calif., July 21, 2020 /PRNewswire/ -- A new study shows significant benefits of the Ellipsys ® Vascular Access System in easily and safely creating durable vascular access for end ...

The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week's Controversies in Dialysis Access (CiDA) 15 th Anniversary Meeting, ...

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study ...

MUSKOGEE, Okla.--(BUSINESS WIRE)--The Chief of Surgery at the Jack C. Montgomery VA Medical Center, Dr. Mark Randel, recently performed a new revolutionary vascular procedure for patients requiring ...

WASHINGTON--(BUSINESS WIRE)--The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week’s Controversies in Dialysis Access (CiDA) ...

SAN JUAN CAPISTRANO, Calif., March 3, 2020 /PRNewswire/ -- The Ellipsys ® Vascular Access System enables patients with kidney failure to start dialysis treatment sooner with fewer procedures, ...

Last month at the Society for Vascular Surgery’s 2019 Vascular Annual Meeting, vascular surgeon Alexandros Mallios, M.D. of Institut Mutualiste Montsouris of Paris, France presented his two year ...

San Juan Capistrano, Calif. -- A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection ...

Please provide your email address to receive an email when new articles are posted on . Medtronic plc. announced plans to acquire Avenu Medical, a California-based company which focuses on developing ...

The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...

A new catheter-based technology could provide a non-surgical option for arteriovenous (AV) fistula creation. FDA recently gave de novo clearance to Avenu Medical’s Ellipsys Vascular Access System. The ...